Exploring Mental Health Insights through EEG
Our mission is to accelerate
the pathway to recovery from depression
Join Newsletter
THE PROBLEM
Biomarkers in Depression
Challenges
There are no clinically translated biomarkers for depression
A New Frontier in Measurement
The default mode network (DMN) is an promising candidate, related to symptoms such as rumination.
Real-time EEG Analysis
We clinically translate EEG measures for prognostic and therapeutic devices.
GOAL STATEMENT
We’re enabling a new paradigm of depression treatment and measurement.
Current Research Collaborations
TMS Prediction
Using EEG to predict Transcranial Magnetic Stimulation (TMS) outcomes in treatment-resistant depression, in collaboration with A/Prof Luca Cocchi
DMN Modulation
Validating our neural network modulation approach in healthy participants - in collaboration with Dr Stevan Nikolin
KEY RESEARCH PAPERS
OUR TEAM
We're bringing together a team of researchers, engineers, and clinicians.
After nearly 8 years working in neuroscience research at Oxford University, I identified an opportunity to develop a new medical device for depression treatment. Blending my background in both cutting-edge research and setting up supply chains in complex markets, I launched Resonait to build a new device and get it to market where it can have a real impact on patients’ lives.
Get In Touch
Whether you're a clinician, investor, or researcher, we'd love to hear from you! Stay in touch with our monthly newsletter.
Our Contact Info
+61 423 344 596
cam@resonait.com